Process for the resolution of racemates of optically active bicyclic imino-.alpha.-carboxylic esters
AssigneeHoechst Aktiengesellschaft
InventorsRolf Geiger, Volker Teetz, Dietrich Langner
Life of this patent
Estimating the term…
Loading patent…
AssigneeHoechst Aktiengesellschaft
InventorsRolf Geiger, Volker Teetz, Dietrich Langner
Estimating the term…
The invention relates to a process for resolving racemic mixtures of bicyclic imino-.alpha.-carboxylic esters into the components by crystallization of diastereomeric salts, which comprises preparing the salts of the racemic esters with optionally active N-acylated R- or S-aminocarboxylic acids which contain a phenyl nucleus, recrystallizing them from an organic solvent, decomposing the precipitated, optically homogeneous diastereomeric salts in a manner known per se, and isolating the enantiomers and, where appropriate, converting the latter into the free acids by hydrolysis in a manner known per se. The invention also relates to optically pure compounds of the formula ##STR1## and to diastereomeric salts of these compounds, in which two of the radicals A, B.sup.1, B.sup.2 and C form a carbon chain and the other denote hydrogen, and R is an esterifying group.
Cis,endo-2-Azabicyclo[3.3.0]octane-3S-carboxylic acid, essentially free of other isomers.
A cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic ester, essentially free of other isomers, in which the ester group is denoted by --COOR, where R represents alkyl having 1 to 6 carbon atoms, cycloalkyl having 4 to 8 carbon atoms or aralkyl having 7 to 13 carbon atoms which can optically be substituted by NO.sub.2.
Benzyl cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylate, essentially free of other isomers.
A cis,endo-octahydro[1H]indole-2S-carboxylic ester, essentially free of other isomers, in which the ester group is denoted by --COOR, where R represents alkyl having 1 to 6 carbon atoms, cycloalkyl having 4 to 8 carbon atoms or aralkyl having 7 to 13 carbon atoms which can optionally be substituted by NO.sub.2.
Benzyl cis,endo-octahydro[1H]indole-2S-carboxylate, essentially free of other isomers.
Dependencies are inferred from the claim text.